RBP4 Antagonist (iCura Vision)

N/A

Report date: 2025/06/11 10:24:36
NME

Base Information

Drug NameRBP4 Antagonist (iCura Vision)
Drug Alias NameRBP4 antagonist (Columbia university)ICR-14967BPN-3855BPN-14136
ClassificationSmall molecules
Mechanisms of ActionRetinol-binding protein 4 inhibitors
TargetsRetinol-binding protein 4
Therapy Area/IndicationsGeographic AtrophyMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesiCura VisionColumbia University
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A